Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02781246Phase 4Unknown
Phase 4, randomised trial of dexmedetomidine in pain (5 arms). Primary endpoints: Minimum Local Anesthetic Concentration at 30 minutes, Postoperative pain at 12 hours and 1 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02781246.